Heroin is an extremely “clean” opiate; it’s a pure agonist with a very short half-life. Because of this, ibogaine will successfully eliminate those brutally painful and long-lasting withdrawal symptoms. We will work with the patient to try and lower their heroin consumption to a single gram or less the day before ibogaine consumption.
Hydromorphone (Dilaudid), oxycodone (Oxycontin), fentanyl and fentanyl analogs, codeine, MS Contin (controlled-release morphine sulfate) and hydrocodone are extremely compatible with ibogaine. They’re all pure agonists, and relatively short-acting opioids, with no extended half-life. For patients using Oxycontin we will need to have your dose lowered to 120mg or less the day before we can administer ibogaine.
Due to the possibility of shaking, seizures, DTs and temporary psychosis when refraining from drinking alcohol we will provide a doctor to supervise the initial detox off of alcohol. After 5 days of detoxification a liver panel blood test will be done and, if possible, ibogaine will then be administered safely and thoroughly.
Amphetamines speed up the heart and so does iboga, for this reason your first ibogaine dose won’t be given until your fourth day at our center. This would include meth, ephedra, Adderall and other ADHD medications.
Cocaine speeds up the heart and so does iboga, for this reason your first ibogaine dose won’t be given until your fourth day at our center. Because ibogaine contains a long-lasting metabolite it can become an effective solution in alleviating the worst side-effects of cocaine withdrawal and craving.
Methadone has a longer half-life than morphine, heroin, or oxycodone, it is a relatively “clean” molecule, that acts as a pure agonist at opiate receptors. *For patients using methadone generally the rule is the longer you can stay the higher the success rate.
Suboxone and subutex are long acting opioids. Go Ibogaine has a unique protocol for people addicted to these prescription drugs because of this. The challenge with longer acting opiates/opioids is post acute withdrawal syndrome (PAWS) that can linger after an initial detox from these drugs. We do not want a person to go home shortly after the initial detox and start feeling withdrawals at a later date. *For patients using suboxone/subutex generally the rule is the longer you can stay the higher the success rate.
If there are any questions or concerns about other drugs of misuse and the effects of ibogaine treatment for them please feel free to call us now. This includes but is not limited to nicotine, research chemicals, benzodiazepines, dissociatives, spice (synthetic cannabinoids), bath salts & flaca (cathinone derivatives), substituted phenylethylamines, etc.
Ibogaine has been demonstrated to modulate the uptake of various neurotransmitter systems, restoring a level of balance, and to be neuro-protective of dopamine receptors, which play a role in mood disorders.
Ibogaine creates a state of plasticity similar to states of plasticity existing during fetal development. This critical brain state may facilitate the consolidation of traumatic memories, reversal of abnormal cerebral hemisphere functions, and the dissolution of habitual motor patterns associated with addiction.
While most patients undergo ibogaine therapy as a way to recover from serious drug addiction, this type of treatment can also trigger recoveries from many other psychological issues including depression, anxiety, and trauma. The ibogaine’s profoundly personal and enlightening qualities also allows the participant to let go of different habitual behaviors not related to drug use that may be equally difficult for them to break. This is especially life changing for victims of chronic depression, anxiety disorders, OCD, childhood trauma and post-traumatic stress disorder (PTSD), which often cause such intense emotional stress that recovery seems impossible. For people who suffer from these terrible chronic afflictions, ibogaine offers a bright ray of hope backed by hundreds of years of traditional use, many thousands of successful anecdotal cases, and more and more scientific validation.
As Ibogaine has the ability to heal the mind it also is very effective at healing the nervous system and body of a person and so many co-occurring physical ailments that accompany mental health issues can be resolved too. Depression, anxiety, post-traumatic stress disorder (PTSD), compulsive disorder (OCD), and attention deficit hyperactivity disorder (ADHD) are just a few of the mental health conditions in which Ibogaine has proven beneficial.
The ability of Ibogaine to influence psycho-spiritual change means that it works on the part of a person’s psyche that creates many mental diseases and mood disorders. To be more specific, it works on the motor neuron pathways as well as the higher consciousness, both of which affect the capacity of the individual to understand their past with acceptance and release the various unhealthy psychological binders. By allowing this to happen the medicine paves a way for the possibility of a free and joy-filled future.
Most patients that have used ibogaine for mental health treatment attest that it not only reinstates you to a state of mental clarity, which gives you a mental picture of a magnificent opportunity-filled future, it will also leave you at a place where you are free from crippling emotions.
When it comes to the cause psychological disorders, there are many theories including vaccines, trauma, genetics, and poor infancy and childhood development. The reality is less clear and it may be some or all of these things that lead to mental health disorders. We do know though that with these disorders that the neurochemistry changes and many people have a hard time overcoming these problems. Ibogaine has the potential to help restore the chemical balance and liberate the patient from unhealthy mental states of anxiety, depression, and mania by allowing their body and mind to clear itself of years of instigating causes.
Mental illnesses affect the person’s ability to interpret or process past experiences, which is a requisite for life improvement. Ibogaine treatment for mental health brings clarity where emotions are freed as chemical balance is restored. This eliminates the stressors for these disorders.
Depressive disorders comprise a leading cause of the world’s disease burden, and that by 2020 depression may become the second largest burden on global health and healthcare systems. Other psychiatric disorders such as anxiety, post-traumatic stress, social anxiety disorder, etc. affect a growing part of the population in the United States and elsewhere.
Depressive disorders encompass major depressive disorder, dysthymic disorder, and bipolar disorder. Bipolar disorder is included because people with this illness have depressive episodes as well as manic episodes.
Approximately 18.8 million American adults, or about 9.5 percent of the U.S. population age 18 and older in a given year, have a depressive disorder.
Nearly twice as many women (12.0 percent) as men (6.6 percent) are affected by a depressive disorder each year. These figures translate to 12.4 million women and 6.4 million men in the U.S.
Depressive disorders may be appearing earlier in life in people born in recent decades compared to the past.
Depressive disorders often co-occur with anxiety disorders and substance abuse..
More than 90 percent of people who kill themselves have a diagnosable mental disorder, commonly a depressive disorder or a substance abuse disorder.
The highest suicide rates in the U.S. are found in white men over age 85.
The suicide rate in young people increased dramatically over the last few decades. In 1997, suicide was the 3rd leading cause of death among 15 to 24 year olds.
Four times as many men than women commit suicide; however, women attempt suicide 2-3 times as often as men.
Attention Deficit Hyperactivity Disorder (ADHD)
ADHD, one of the most common mental disorders in children and adolescents, affects an estimated 4.1 % of youths ages 9 to 17 in a 6-month period.
About 2-3 times more boys than girls are affected.
ADHD usually becomes evident in preschool or early elementary years. The disorder frequently persists into adolescence and occasionally into adulthood.
Approximately 2.2 million American adults, or about 1.1 % of the population age 18 and older in a given year, have schizophrenia.
Schizophrenia affects men and women with equal frequency.
Schizophrenia often first appears earlier in men, usually in their late teens or early 20s, than in women, who are generally affected in their 20s or early 30s.
Anxiety disorders include panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, generalized anxiety disorder, and phobias (social phobia, agoraphobia, and specific phobia).
Approximately 19.1 million American adults ages 18 to 54, or about 13.3 percent of people in this age group in a given year, have an anxiety disorder.
Anxiety disorders frequently co-occur with depressive disorders, eating disorders, or substance abuse.
Many people have more than one anxiety disorder.
Women are more likely than men to have an anxiety disorder. Approximately twice as many women as men suffer from panic disorder, post-traumatic stress disorder, generalized anxiety disorder, agoraphobia, and specific phobia, though about equal numbers of women and men have obsessive-compulsive disorder and social phobia.